Tempus AI, Inc.

ISIN US88023B1035

 | 

WKN A40EDP

Market cap (in EUR)
11,177 m
Country
United States
Sector
Healthcare
 

Overview

Description

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
Show more Show less
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States

Financials

Key metrics

Market capitalisation, EUR 11,177 m
EPS, EUR -1.07
P/B ratio 25.8
P/E ratio -
Dividend yield -

Income statement (2024)

Revenue, EUR 641 m
Net income, EUR -652 m
Profit margin -101.79%

What ETF is Tempus AI, Inc. in?

There are 4 ETFs which contain Tempus AI, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Tempus AI, Inc. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.26%
Equity
United States
Health Care
Biotech
43
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
485
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.13%
Equity
United States
Small Cap
178
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.